Due to CrossFit's official partnership with Reebok, competitors at the 2015 Games were banned from wearing Nike footwear. Nike arranged for several trucks to be parked near the main entrance to the arena, which served as mobile billboards with the slogan "Don't ban our shoe, beat our shoe". The partnership also prohibits Nike from labeling its Metcon shoes as intended for CrossFit – the brand uses the term "high intensity training" instead.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”